25 LLC’s Fulgent Genetics FLGT Stock Holding History

25 LLC’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17	Closed	-$666	–	209
2023 Q2	$666	Hold	17	–	–	﹤0.01%	341
2023 Q1	$563	Buy	+17	New	+$547	﹤0.01%	279

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

25 LLC's FLGT Position: Q3 2023 in Review

25 LLC sold out of Fulgent Genetics (FLGT) in Q3 2023, closing a stake of 17 shares — an estimated $666 sold.

25 LLC first reported a position in FLGT in Q1 2023 and held it in 2 quarters. The position peaked at $666 in Q2 2023. 201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

25 LLC reported no remaining Fulgent Genetics position as of Q3 2023 after selling out during the quarter.
25 LLC sold 17 Fulgent Genetics shares in Q3 2023, an estimated $666.
25 LLC first reported a position in Fulgent Genetics in Q1 2023 and held it in 2 quarters.
25 LLC's Fulgent Genetics position peaked at $666 in Q2 2023.
201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.